131 related articles for article (PubMed ID: 3485470)
21. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer.
Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Hermans J; Buys CC; Plukker JT
Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374
[TBL] [Abstract][Full Text] [Related]
22. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
23. Patterns of recurrence after curative resection of carcinoma of the colon and rectum.
Galandiuk S; Wieand HS; Moertel CG; Cha SS; Fitzgibbons RJ; Pemberton JH; Wolff BG
Surg Gynecol Obstet; 1992 Jan; 174(1):27-32. PubMed ID: 1729745
[TBL] [Abstract][Full Text] [Related]
24. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
26. [Colorectal cancer. A study of 133 surgical cases].
Arthur KE; Perurena J
Rev Med Panama; 1993 Jan; 18(1):1-15. PubMed ID: 8475334
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01).
Fisher ER; Paik SM; Rockette H; Jones J; Caplan R; Fisher B
Hum Pathol; 1989 Feb; 20(2):159-63. PubMed ID: 2562788
[TBL] [Abstract][Full Text] [Related]
28. A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis?
Bentzen SM; Balslev I; Pedersen M; Teglbjaerg PS; Hanberg-Soerensen F; Bone J; Jacobsen NO; Overgaard J; Sell A; Bertelsen K
Br J Cancer; 1988 Aug; 58(2):195-201. PubMed ID: 3166910
[TBL] [Abstract][Full Text] [Related]
29. Is earlier referral and investigation of bowel cancer patients presenting with rectal bleeding associated with better survival?
Thompson MR; Asiimwe A; Flashman K; Tsavellas G
Colorectal Dis; 2011 Nov; 13(11):1242-8. PubMed ID: 20883523
[TBL] [Abstract][Full Text] [Related]
30. Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum.
Rao B; Wanebo HJ; Pinsky C; Stearns M; Oettgen HF
Surg Gynecol Obstet; 1977 May; 144(5):677-81. PubMed ID: 850850
[TBL] [Abstract][Full Text] [Related]
31. Jass' classification revisited.
Deans GT; Heatley M; Anderson N; Patterson CC; Rowlands BJ; Parks TG; Spence RA
J Am Coll Surg; 1994 Jul; 179(1):11-7. PubMed ID: 8019715
[TBL] [Abstract][Full Text] [Related]
32. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
33. Staging of carcinoma of the colon and rectum.
Roseman DL; Straus AK
Surg Gynecol Obstet; 1980 Jul; 151(1):93-5. PubMed ID: 7384992
[TBL] [Abstract][Full Text] [Related]
34. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.
Johnston PG; Fisher ER; Rockette HE; Fisher B; Wolmark N; Drake JC; Chabner BA; Allegra CJ
J Clin Oncol; 1994 Dec; 12(12):2640-7. PubMed ID: 7989939
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of sealed-off perforation in colon cancer: a prospective cohort study.
Lee KY; Park JW; Song I; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
World J Surg Oncol; 2018 Dec; 16(1):232. PubMed ID: 30514318
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials.
Wolmark N; Fisher B; Wieand HS; Henry RS; Lerner H; Legault-Poisson S; Deckers PJ; Dimitrov N; Gordon PH; Jochimsen P
Ann Surg; 1984 Apr; 199(4):375-82. PubMed ID: 6370155
[TBL] [Abstract][Full Text] [Related]
38. Extrarectal colonic carcinoma: analysis of 138 cases with long-term follow-up.
Saliba S; Rosales W; Escallon A; Aldrete JS
South Med J; 1986 Jan; 79(1):12-6, 20. PubMed ID: 2418506
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of human telomerase reverse transcriptase in patients with colon cancer].
Li LR; Wan DS; Pan ZZ; Hardingham J; Rieger N; Hewett P; Zhou ZW; Chen G
Ai Zheng; 2004 Nov; 23(11 Suppl):1502-7. PubMed ID: 15566667
[TBL] [Abstract][Full Text] [Related]
40. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04.
Wolmark N; Rockette H; Mamounas E; Jones J; Wieand S; Wickerham DL; Bear HD; Atkins JN; Dimitrov NV; Glass AG; Fisher ER; Fisher B
J Clin Oncol; 1999 Nov; 17(11):3553-9. PubMed ID: 10550154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
